» Articles » PMID: 38107713

Cut-off Values for IL-21 and IL-23 As Biochemical Markers for Pemphigus Vulgaris

Overview
Journal J Med Life
Specialty General Medicine
Date 2023 Dec 18
PMID 38107713
Authors
Affiliations
Soon will be listed here.
Abstract

Pemphigus vulgaris (PV) is a potentially fatal mucocutaneous autoimmune disease characterized by severe skin lesions. Interleukin-21 (IL-21) and IL-23 have been linked to several autoimmune inflammatory diseases that may have a critical role in PV immunopathogenesis, including T-helper 17 (Th17) development. This study aimed to compare the serum levels of IL-21 and IL-23 in patients with PV and healthy controls. This case-control study included 90 participants (45 patients and 45 controls). Serum IL-21 and IL-23 were measured using the Sandwich-ELISA method provided by Sunlong Biotech, China. The findings revealed statistically significant results for IL-21 O.D. and Conc. (p=0.012*) and highly significant results for IL-23 O.D. and Conc. (p=0.000**). Furthermore, cut-off values were established for IL-21 (O.D.=0.071 pg/mL, Conc.=6.468 pg/mL) and IL-23 (O.D.=0.141 pg/mL, Conc.=6.745 pg/mL). These results indicate a potential association between PV and IL-21, IL-23, and the identified cut-off values. The particular roles of cytokines and how they can be utilized to treat PV require more investigation. To our knowledge, this was the first study to detect a cut-off point for IL-21 and IL-23 that may be used as novel and cost-effective biochemical markers for disease diagnosis.

References
1.
Abdullameer M, Abdulkareem A . Diagnostic potential of salivary interleukin-17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case-control study. Health Sci Rep. 2023; 6(2):e1103. PMC: 9900720. DOI: 10.1002/hsr2.1103. View

2.
Serwin A, Koper M, Flisiak I . Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study. Int J Dermatol. 2018; 57(8):933-937. DOI: 10.1111/ijd.14078. View

3.
Abdo A, Tye G . Interleukin 23 and autoimmune diseases: current and possible future therapies. Inflamm Res. 2020; 69(5):463-480. DOI: 10.1007/s00011-020-01339-9. View

4.
Alshami M, Aswad F, Abdullah B . A clinical and demographic analysis of oral pemphigus vulgaris: A retrospective cross-sectional study from 2001 to 2021. Health Sci Rep. 2022; 5(5):e832. PMC: 9470012. DOI: 10.1002/hsr2.832. View

5.
Pollmann R, Schmidt T, Eming R, Hertl M . Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches. Clin Rev Allergy Immunol. 2018; 54(1):1-25. DOI: 10.1007/s12016-017-8662-z. View